Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Dawid M Zakrzewski, Patrycja Podlejska, Wiktoria Kubziakowska, Kamil Dzwilewski, Przemysław M Waszak, Marta Zawadzka, Maria Mazurkiewicz-Bełdzińsk. Evaluating the Credibility and Reliability of Online Information on Cannabidiol (CBD) for Epilepsy Treatment in Poland. Healthcare (Basel, Switzerland). vol 12. issue 8. 2024-04-26. PMID:38667591. |
evaluating the credibility and reliability of online information on cannabidiol (cbd) for epilepsy treatment in poland. |
2024-04-26 |
2024-04-28 |
Not clear |
Dawid M Zakrzewski, Patrycja Podlejska, Wiktoria Kubziakowska, Kamil Dzwilewski, Przemysław M Waszak, Marta Zawadzka, Maria Mazurkiewicz-Bełdzińsk. Evaluating the Credibility and Reliability of Online Information on Cannabidiol (CBD) for Epilepsy Treatment in Poland. Healthcare (Basel, Switzerland). vol 12. issue 8. 2024-04-26. PMID:38667591. |
the aim of our work was to evaluate the information contained on the websites, including social media, in terms of the credibility and the reliability of current knowledge about the usage of products containing cannabidiol in epilepsy treatment. |
2024-04-26 |
2024-04-28 |
Not clear |
Correction to "Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program". Epilepsia. 2024-04-04. PMID:38572913. |
correction to "efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the expanded access program". |
2024-04-04 |
2024-04-06 |
Not clear |
Mohamed Osman, Jamileh Khalil, Mostafa El-Bahri, Jamal Swalah Mcdahrou, Reem Fahda, Reymin Mustafa, Arthur Ooi, Marwa Attayee, Rachelle Catanzariti, Lisa Pont, Kylie Williams, Stewart Yeung, Kamal Dua, Gabriele De Rubis, Raimar Loebenber. Decoding epilepsy treatment: A comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations. Chemico-biological interactions. 2024-04-04. PMID:38574834. |
decoding epilepsy treatment: a comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations. |
2024-04-04 |
2024-04-07 |
Not clear |
Yasaman Javadzadeh, Alexandra Santos, Mark S Aquilino, Shanthini Mylvaganam, Karolina Urban, Peter L Carle. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ Cells. vol 13. issue 6. 2024-03-27. PMID:38534310. |
cannabidiol exerts anticonvulsant effects alone and in combination with Δ cannabinoids have shown potential in drug-resistant epilepsy treatment; however, we lack knowledge on which cannabinoid(s) to use, dosing, and their pharmacological targets. |
2024-03-27 |
2024-03-29 |
Not clear |
Correction to "Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program". Epilepsia. 2024-03-19. PMID:38502122. |
correction to "long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: four-year results from the expanded access program". |
2024-03-19 |
2024-03-21 |
Not clear |
Giovanni Battista Dell'isola, Alberto Verrotti, Miriam Sciaccaluga, Gianluca Dini, Pietro Ferrara, Lucilla Parnetti, Cinzia Cost. Cannabidiol: metabolism and clinical efficacy in epileptic patients. Expert opinion on drug metabolism & toxicology. 2024-03-11. PMID:38465404. |
the landscape of epilepsy treatment has undergone a significant transformation with the emergence of cannabidiol as a potential therapeutic agent. |
2024-03-11 |
2024-03-14 |
Not clear |
Correction to "Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program". Epilepsia. 2024-02-29. PMID:38420790. |
correction to "long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: four-year results from the expanded access program". |
2024-02-29 |
2024-03-02 |
Not clear |
Ayushe A Sharma, Jerzy P Szaflarsk. The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 151. 2024-01-10. PMID:38199054. |
the longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. |
2024-01-10 |
2024-01-13 |
human |
Christopher Martínez-Aguirre, Luis Alfredo Márquez, Cindy Lizbeth Santiago-Castañeda, Francia Carmona-Cruz, Maria de Los Angeles Nuñez-Lumbreras, Vladimir A Martínez-Rojas, Mario Alonso-Vanegas, Gustavo Aguado-Carrillo, Norma L Gómez-Víquez, Emilio J Galván, Manola Cuéllar-Herrera, Luisa Roch. Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study. Biomedicines. vol 11. issue 12. 2023-12-23. PMID:38137458. |
cannabidiol modifies the glutamate over-release in brain tissue of patients and rats with epilepsy: a pilot study. |
2023-12-23 |
2023-12-25 |
rat |
Long Chen, Yuan Sun, Jinran Li, Sai Liu, Hancheng Ding, Guangji Wang, Xinuo L. Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration. Cells. vol 12. issue 23. 2023-12-09. PMID:38067101. |
cannabidiol (cbd), derived from cannabis, is noted for its neuroprotective and anti-inflammatory properties, having shown efficacy in neuropathic pain management for epilepsy. |
2023-12-09 |
2023-12-17 |
Not clear |
Anumita Samanta, Adrian Aleman-Zapata, Kopal Agarwal, Pelin Özsezer, Alejandra Alonso, Jacqueline van der Meij, Abdelrahman Rayan, Irene Navarro-Lobato, Lisa Genze. CBD lengthens sleep but shortens ripples and leads to intact simple but worse cumulative memory. iScience. vol 26. issue 11. 2023-12-01. PMID:38026151. |
cannabidiol (cbd) is on the rise as over-the-counter medication to treat sleep disturbances, anxiety, pain, and epilepsy due to its action on the excitatory/inhibitory balance in the brain. |
2023-12-01 |
2023-12-10 |
rat |
Michal Tzadok, Rotem Gur-Pollack, Hadar Florh, Yael Michaeli, Tal Gilboa, Mirit Lezinger, Eli Heyman, Veronika Chernuha, Irina Gudis, Andreea Nissenkorn, Tally Lerman-Sagie, Bruria Ben Zeev, Shimrit Uliel-Sibon. Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective Study. Pediatric neurology. vol 150. 2023-11-23. PMID:37995414. |
real-life experience with purified cannabidiol treatment for refractory epilepsy: a multicenter retrospective study. |
2023-11-23 |
2023-11-29 |
Not clear |
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. |
the impact of recreational cannabis use on neuropsychological function in epilepsy. |
2023-11-13 |
2023-11-20 |
Not clear |
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. |
cannabis use is associated with neuropsychological impairments in the general population, but little is known about the impact on cognitive function in people with epilepsy who are already at increased risk of difficulties due to the essential comorbidities of the disease. |
2023-11-13 |
2023-11-20 |
Not clear |
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. |
we compared the performance of 42 people with epilepsy (pwe) who reported regular cannabis use with 254 age matched, non-cannabis-using pwe. |
2023-11-13 |
2023-11-20 |
Not clear |
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. |
cannabis use was not associated with epilepsy type. |
2023-11-13 |
2023-11-20 |
Not clear |
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. |
our data indicates that recreational cannabis use in people with epilepsy amplifies deficits in new learning and enhances susceptibility to distraction in the retention of newly learnt material. |
2023-11-13 |
2023-11-20 |
Not clear |
Shengyi Liu, Zihua He, Jinmei L. Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis. Therapeutic advances in neurological disorders. vol 16. 2023-11-02. PMID:37915501. |
long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis. |
2023-11-02 |
2023-11-08 |
Not clear |
Aaron J Rozental, Brooke G Weisbeck, Isabella Corsato Alvarenga, Daniel L Gustafson, Breonna R Kusick, Sangeeta Rao, Lisa R Bartner, Stephanie McGrat. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. Journal of veterinary internal medicine. 2023-10-27. PMID:37889215. |
the efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: a double-blinded crossover study. |
2023-10-27 |
2023-11-08 |
Not clear |